The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection
The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whilst antibody-mediated immune responses rely on HLA class II antigen presentation to CD4+ T cells, cytotoxic CD8+ T cell responses are primed via the HLA class I antigen presentation pathway and can provide potent protection against infection by eradicating infected cells and preventing viral spreading12–15.”
From Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes (2024) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SCANPY: large-scale single-cell gene expression data analysis
Wolf, F. A., Angerer, P., & Theis, F. J. (2018) · Genome Biology · doi:10.1186/s13059-017-1382-0 · Cited by 8,881
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
Simultaneous epitope and transcriptome measurement in single cells
Stoeckius, M., Hafemeister, C., Stephenson, W., Houck-Loomis, B., Chattopadhyay, P. K., Swerdlow, H., Satija, R., & Smibert, P. (2017) · Nature Methods · doi:10.1038/nmeth.4380 · Cited by 3,098
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.
Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., et al. (2021) · Science · doi:10.1126/science.abf4063 · Cited by 2,656
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Sahin, U., Derhovanessian, E., Miller, M., Kloke, B.-P., Simon, P., Löwer, M., Bukur, V., Tadmor, A. D., Luxemburger, U., Schrörs, B., et al. (2017) · Nature · doi:10.1038/nature23003 · Cited by 2,488
Self-citationOmicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Cao, Y., Wang, J., Jian, F., Xiao, T., Song, W., Yisimayi, A., Huang, W., Li, Q., Wang, P., An, R., et al. (2022) · Nature · doi:10.1038/s41586-021-04385-3 · Cited by 2,006
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
Sahin, U., Muik, A., Derhovanessian, E., Vogler, I., Kranz, L. M., Vormehr, M., Baum, A., Pascal, K., Quandt, J., Maurus, D., et al. (2020) · Nature · doi:10.1038/s41586-020-2814-7 · Cited by 1,977
Self-citationSARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
Le Bert, N., Tan, A. T., Kunasegaran, K., Tham, C. Y. L., Hafezi, M., Chia, A., Chng, M. H. Y., Lin, M., Tan, N., Linster, M., et al. (2020) · Nature · doi:10.1038/s41586-020-2550-z · Cited by 1,887
Adaptive immunity to SARS-CoV-2 and COVID-19
Sette, A., & Crotty, S. (2021) · Cell · doi:10.1016/j.cell.2021.01.007 · Cited by 1,860
Rydyznski Moderbacher, C., Ramirez, S. I., Dan, J. M., Grifoni, A., Hastie, K. M., Weiskopf, D., Belanger, S., Abbott, R. K., Kim, C., Choi, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.038 · Cited by 1,790
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788
Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0782-6 · Cited by 1,179
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
Mateus, J., Grifoni, A., Tarke, A., Sidney, J., Ramirez, S. I., Dan, J. M., Burger, Z. C., Rawlings, S. A., Smith, D. M., Phillips, E., et al. (2020) · Science · doi:10.1126/science.abd3871 · Cited by 1,120
Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques
McMahan, K., Yu, J., Mercado, N. B., Loos, C., Tostanoski, L. H., Chandrashekar, A., Liu, J., Peter, L., Atyeo, C., Zhu, A., et al. (2021) · Nature · doi:10.1038/s41586-020-03041-6 · Cited by 1,068
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
Bojkova, D., Klann, K., Koch, B., Widera, M., Krause, D., Ciesek, S., Cinatl, J., & Münch, C. (2020) · Nature · doi:10.1038/s41586-020-2332-7 · Cited by 1,010
Lethal Infection of K18- hACE2 Mice Infected with Severe Acute Respiratory Syndrome Coronavirus
McCray, P. B., Pewe, L., Wohlford-Lenane, C., Hickey, M., Manzel, L., Shi, L., Netland, J., Jia, H. P., Halabi, C., Sigmund, C. D., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02012-06 · Cited by 1,010
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans
Sahin, U., Muik, A., Vogler, I., Derhovanessian, E., Kranz, L. M., Vormehr, M., Quandt, J., Bidmon, N., Ulges, A., Baum, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03653-6 · Cited by 919
Self-citationBNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans
Sahin, U., Muik, A., Vogler, I., Derhovanessian, E., Kranz, L. M., Vormehr, M., Quandt, J., Bidmon, N., Ulges, A., Baum, A., et al. (2020) · doi:10.1101/2020.12.09.20245175 · Cited by 914
Self-citationAlarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
Wang, Q., Iketani, S., Li, Z., Liu, L., Guo, Y., Huang, Y., Bowen, A. D., Liu, M., Wang, M., Yu, J., et al. (2023) · Cell · doi:10.1016/j.cell.2022.12.018 · Cited by 912
Tan, A. T., Linster, M., Tan, C. W., Le Bert, N., Chia, W. N., Kunasegaran, K., Zhuang, Y., Tham, C. Y. L., Chia, A., Smith, G. J. D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108728 · Cited by 740
BNT162b vaccines protect rhesus macaques from SARS-CoV-2
Vogel, A. B., Kanevsky, I., Che, Y., Swanson, K. A., Muik, A., Vormehr, M., Kranz, L. M., Walzer, K. C., Hein, S., Güler, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03275-y · Cited by 694 · cited 7×
“BNT162b4 encodes segments of the SARS-CoV-2 N, M, and ORF1ab proteins and is intended to be administered with S-protein-encoding vaccines, such as BNT162b2.(41,42) Here we show that BNT162b4 generates T cell epitopes presented on HLA-I complexes in human cell lines detectable bymass spectrometry (MS).”
InfluentialSelf-citationSARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
Nelde, A., Bilich, T., Heitmann, J. S., Maringer, Y., Salih, H. R., Roerden, M., Lübke, M., Bauer, J., Rieth, J., Wacker, M., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00808-x · Cited by 582
Tarke, A., Sidney, J., Kidd, C. K., Dan, J. M., Ramirez, S. I., Yu, E. D., Mateus, J., da Silva Antunes, R., Moore, E., Rubiro, P., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100204 · Cited by 540
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
Bange, E. M., Han, N. A., Wileyto, P., Kim, J. Y., Gouma, S., Robinson, J., Greenplate, A. R., Hwee, M. A., Porterfield, F., Owoyemi, O., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01386-7 · Cited by 519
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera
Muik, A., Wallisch, A.-K., Sänger, B., Swanson, K. A., Mühl, J., Chen, W., Cai, H., Maurus, D., Sarkar, R., Türeci, Ö., et al. (2021) · Science · doi:10.1126/science.abg6105 · Cited by 515
Self-citationNeutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
Muik, A., Wallisch, A.-K., Sänger, B., Swanson, K. A., Mühl, J., Chen, W., Cai, H., Sarkar, R., Türeci, Ö., Dormitzer, P. R., et al. (2021) · doi:10.1101/2021.01.18.426984 · Cited by 515
Self-citationT cell-mediated immune response to respiratory coronaviruses
Channappanavar, R., Zhao, J., & Perlman, S. (2014) · Immunologic Research · doi:10.1007/s12026-014-8534-z · Cited by 512
Painter, M. M., Mathew, D., Goel, R. R., Apostolidis, S. A., Pattekar, A., Kuthuru, O., Baxter, A. E., Herati, R. S., Oldridge, D. A., Gouma, S., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.08.001 · Cited by 499
Airway Memory CD4+ T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses
Zhao, J., Zhao, J., Mangalam, A. K., Channappanavar, R., Fett, C., Meyerholz, D. K., Agnihothram, S., Baric, R. S., David, C. S., & Perlman, S. (2016) · Immunity · doi:10.1016/j.immuni.2016.05.006 · Cited by 496
Davidson, A. D., Williamson, M. K., Lewis, S., Shoemark, D., Carroll, M. W., Heesom, K. J., Zambon, M., Ellis, J., Lewis, P. A., Hiscox, J. A., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-00763-0 · Cited by 457
Cohen, K. W., Linderman, S. L., Moodie, Z., Czartoski, J., Lai, L., Mantus, G., Norwood, C., Nyhoff, L. E., Edara, V. V., Floyd, K., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100354 · Cited by 441
Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection
Ng, O.-W., Chia, A., Tan, A. T., Jadi, R. S., Leong, H. N., Bertoletti, A., & Tan, Y.-J. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.02.063 · Cited by 436
Channappanavar, R., Fett, C., Zhao, J., Meyerholz, D. K., & Perlman, S. (2014) · Journal of Virology · doi:10.1128/jvi.01505-14 · Cited by 411
Kustin, T., Harel, N., Finkel, U., Perchik, S., Harari, S., Tahor, M., Caspi, I., Levy, R., Leshchinsky, M., Ken Dror, S., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01413-7 · Cited by 373
Zhao, J., Zhao, J., & Perlman, S. (2010) · Journal of Virology · doi:10.1128/jvi.01049-10 · Cited by 340
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection
Le Bert, N., Clapham, H. E., Tan, A. T., Chia, W. N., Tham, C. Y. L., Lim, J. M., Kunasegaran, K., Tan, L. W. L., Dutertre, C.-A., Shankar, N., et al. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20202617 · Cited by 330
Ferretti, A. P., Kula, T., Wang, Y., Nguyen, D. M. V., Weinheimer, A., Dunlap, G. S., Xu, Q., Nabilsi, N., Perullo, C. R., Cristofaro, A. W., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.006 · Cited by 318
Levine-Tiefenbrun, M., Yelin, I., Alapi, H., Katz, R., Herzel, E., Kuint, J., Chodick, G., Gazit, S., Patalon, T., & Kishony, R. (2021) · doi:10.1101/2021.08.29.21262798 · Cited by 222
Levine-Tiefenbrun, M., Yelin, I., Alapi, H., Katz, R., Herzel, E., Kuint, J., Chodick, G., Gazit, S., Patalon, T., & Kishony, R. (2021) · Nature Medicine · doi:10.1038/s41591-021-01575-4 · Cited by 222
MUON: multimodal omics analysis framework
Bredikhin, D., Kats, I., & Stegle, O. (2022) · Genome Biology · doi:10.1186/s13059-021-02577-8 · Cited by 216
Normalizing and denoising protein expression data from droplet-based single cell profiling
Mulè, M. P., Martins, A. J., & Tsang, J. S. (2022) · Nature Communications · doi:10.1038/s41467-022-29356-8 · Cited by 197
Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters
Yuan, S., Ye, Z.-W., Liang, R., Tang, K., Zhang, A. J., Lu, G., Ong, C. P., Man Poon, V. K., Chan, C. C.-S., Mok, B. W.-Y., et al. (2022) · Science · doi:10.1126/science.abn8939 · Cited by 191
Self-citationSARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8 + T cell responses
Agerer, B., Koblischke, M., Gudipati, V., Montaño-Gutierrez, L. F., Smyth, M., Popa, A., Genger, J.-W., Endler, L., Florian, D. M., Mühlgrabner, V., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg6461 · Cited by 172
Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs
Weingarten-Gabbay, S., Klaeger, S., Sarkizova, S., Pearlman, L. R., Chen, D.-Y., Gallagher, K. M. E., Bauer, M. R., Taylor, H. B., Dunn, W. A., Tarr, C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.05.046 · Cited by 147
CD8 T cells contribute to vaccine protection against SARS-CoV-2 in macaques
Liu, J., Yu, J., McMahan, K., Jacob-Dolan, C., He, X., Giffin, V., Wu, C., Sciacca, M., Powers, O., Nampanya, F., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abq7647 · Cited by 132
Hajnik, R. L., Plante, J. A., Liang, Y., Alameh, M.-G., Tang, J., Bonam, S. R., Zhong, C., Adam, A., Scharton, D., Rafael, G. H., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abq1945 · Cited by 122
Gangaev, A., Ketelaars, S. L. C., Isaeva, O. I., Patiwael, S., Dopler, A., Hoefakker, K., De Biasi, S., Gibellini, L., Mussini, C., Guaraldi, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22811-y · Cited by 111
Lim, J. M. E., Hang, S. K., Hariharaputran, S., Chia, A., Tan, N., Lee, E. S., Chng, E., Lim, P. L., Young, B. E., Lye, D. C., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100793 · Cited by 73
Lafon, E., Diem, G., Witting, C., Zaderer, V., Bellmann-Weiler, R. M., Reindl, M., Bauer, A., Griesmacher, A., Fux, V., Hoermann, G., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.684014 · Cited by 46
Research works printed but not linked: 67
- Cao, 2023, Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution, Nature, 614, 521
- Jian, 2022, Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants, Lancet Infect. Dis., 22, 1535, 10.1016/S1473-3099(22)00642-9 · DOI
- Kurhade, 2022, Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine, Nat. Commun., 13, 3602, 10.1038/s41467-022-30681-1 · DOI
- Muik, A., Lui, B.G., Diao, H., Fu, Y., Bacher, M., Toker, A., Grosser, J., Ozhelvaci, O., Grikscheit, K., Hoehl, S., et al. (2022). Progressive Loss of Conserved Spike Protein Neutralizing Antibody Sites in Omicron Sublineages Is Balanced by Preserved T-Cell Recognition Epitopes. bioRxiv, 2022.2012.2015.520569. 10.1101/2022.12.15.520569 · DOI
- Wherry, 2022, T cell immunity to COVID-19 vaccines, Science, 377, 821, 10.1126/science.add2897 · DOI · Paper page
- Guerrera, 2021, BNT162b2 vaccination induces durable SARS-CoV-2-specific T cells with a stem cell memory phenotype, Sci. Immunol., 6, 10.1126/sciimmunol.abl5344 · DOI · Paper page
- Hurme, 2022, Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients, Front. Immunol., 13, 10.3389/fimmu.2022.869990 · DOI
- Koutsakos, 2023, SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses, Immunity, 56, 879, 10.1016/j.immuni.2023.02.017 · DOI
- Neale, 2023, CD4+ and CD8+ T cell and antibody correlates of protection against Delta vaccine breakthrough infection: A nested case-control study within the PITCH study, medRxiv
- Kent, 2022, Disentangling the relative importance of T cell responses in COVID-19: leading actors or supporting cast?, Nat. Rev. Immunol., 22, 387, 10.1038/s41577-022-00716-1 · DOI · Paper page
- Schulien, 2021, Characterization of pre-existing and induced SARS-CoV-2-specific CD8(+) T cells, Nat. Med., 27, 78, 10.1038/s41591-020-01143-2 · DOI · Paper page
- Kalimuddin, 2021, Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset, Med (N Y), 2, 682
- Matchett, 2021, Cutting Edge: Nucleocapsid Vaccine Elicits Spike-Independent SARS-CoV-2 Protective Immunity, J. Immunol., 207, 376, 10.4049/jimmunol.2100421 · DOI · Paper page
- Carter, 2023, A pan-variant mRNA-LNP T cell vaccine protects HLA transgenic mice from mortality after infection with SARS-CoV-2 Beta, Front. Immunol., 14, 10.3389/fimmu.2023.1135815 · DOI · Paper page
- Swadling, 2022, Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2, Nature, 601, 110, 10.1038/s41586-021-04186-8 · DOI · Paper page
- Foix, 2022, Predicted impact of the viral mutational landscape on the cytotoxic response against SARS-CoV-2, PLoS Comput. Biol., 18, 10.1371/journal.pcbi.1009726 · DOI
- Gauttier, 2020, Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccine, bioRxiv
- Poran, 2020, Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes, Genome Med., 12, 70, 10.1186/s13073-020-00767-w · DOI · Paper page
- Bezstarosti, 2021, Targeted proteomics as a tool to detect SARS-CoV-2 proteins in clinical specimens, PLoS One, 16, 10.1371/journal.pone.0259165 · DOI
- Bouhaddou, 2020, The Global Phosphorylation Landscape of SARS-CoV-2 Infection, Cell, 182, 685, 10.1016/j.cell.2020.06.034 · DOI · Paper page
- Perlman, 2009, Coronaviruses post-SARS: update on replication and pathogenesis, Nat. Rev. Microbiol., 7, 439, 10.1038/nrmicro2147 · DOI · Paper page
- Abelin, 2019, Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction, Immunity, 51, 766, 10.1016/j.immuni.2019.08.012 · DOI · Paper page
- Choi, 2021, Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations, Cell Rep. Methods, 1
- Francis, 2022, Allelic variation in class I HLA determines CD8(+) T cell repertoire shape and cross-reactive memory responses to SARS-CoV-2, Sci. Immunol., 7
- Kared, 2021, SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals, J. Clin. Invest., 131, 10.1172/JCI145476 · DOI · Paper page
- Saini, 2021, SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8(+) T cell activation in COVID-19 patients, Sci. Immunol., 6, 10.1126/sciimmunol.abf7550 · DOI · Paper page
- Kyte, 1982, A simple method for displaying the hydropathic character of a protein, J. Mol. Biol., 157, 105, 10.1016/0022-2836(82)90515-0 · DOI · Paper page
- Vitiello, 1991, Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex, J. Exp. Med., 173, 1007, 10.1084/jem.173.4.1007 · DOI · Paper page
- Sturm, 2020, Scirpy: a Scanpy extension for analyzing single-cell T-cell receptor-sequencing data, Bioinformatics, 36, 4817, 10.1093/bioinformatics/btaa611 · DOI · Paper page
- Twohig, 2022, Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study, Lancet Infect. Dis., 22, 35, 10.1016/S1473-3099(21)00475-8 · DOI · Paper page
- Storm, N., Crossland, N.A., McKay, L.G.A., and Griffiths, A. (2022). Comparative Infection and Pathogenesis of SARS-CoV-2 Omicron and Delta Variants in Aged and Young Syrian Hamsters. bioRxiv, 2022.2003.2002.482662. 10.1101/2022.03.02.482662 · DOI
- Li, 2022, Viral infection and transmission in a large, well-traced outbreak caused by the SARS-CoV-2 Delta variant, Nat. Commun., 13, 460, 10.1038/s41467-022-28089-y · DOI · Paper page
- Abelin, 2017, Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction, Immunity, 46, 315, 10.1016/j.immuni.2017.02.007 · DOI · Paper page
- Schubert, 2016, Designing string-of-beads vaccines with optimal spacers, Genome Med., 8, 9, 10.1186/s13073-016-0263-6 · DOI
- Ali, 2019, Induction of neoantigen-reactive T cells from healthy donors, Nat. Protoc., 14, 1926, 10.1038/s41596-019-0170-6 · DOI
- Shou, 2021, Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates, Front. Microbiol., 12, 10.3389/fmicb.2021.626553 · DOI
- Wellford, 2022, Mucosal plasma cells are required to protect the upper airway and brain from infection, Immunity, 55, 2118, 10.1016/j.immuni.2022.08.017 · DOI
- Suzuki, 2022, Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant, Nature, 603, 700, 10.1038/s41586-022-04462-1 · DOI · Paper page
- Hakki, 2022, Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study, Lancet Respir. Med., 10, 1061, 10.1016/S2213-2600(22)00226-0 · DOI
- Jones, 2021, Estimating infectiousness throughout SARS-CoV-2 infection course, Science, 373, eabi5273, 10.1126/science.abi5273 · DOI · Paper page
- Tang, 2021, BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar, Nat. Med., 27, 2136, 10.1038/s41591-021-01583-4 · DOI · Paper page
- Chandrashekar, 2021, Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants, Sci. Transl. Med., 13, 10.1126/scitranslmed.abj2641 · DOI
- Angyal, 2022, T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study, Lancet. Microbe, 3, e21, 10.1016/S2666-5247(21)00275-5 · DOI · Paper page
- Munoz-Fontela, 2022, Advances and gaps in SARS-CoV-2 infection models, PLoS Pathog., 18, 10.1371/journal.ppat.1010161 · DOI · Paper page
- Dong, 2022, The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus, J. Virol., 96, 10.1128/JVI.00964-21 · DOI · Paper page
- Valyi-Nagy, 2021, Comparison of antibody and T cell responses elicited by BBIBP-CorV (Sinopharm) and BNT162b2 (Pfizer-BioNTech) vaccines against SARS-CoV-2 in healthy adult humans, Geroscience, 43, 2321, 10.1007/s11357-021-00471-6 · DOI
- Brademan, 2019, Interactive Peptide Spectral Annotator: A Versatile Web-based Tool for Proteomic Applications, Mol. Cell. Proteomics, 18, 10.1074/mcp.TIR118.001209 · DOI · Paper page
- Kreiter, 2008, Increased antigen presentation efficiency by coupling antigens to MHC class I trafficking signals, J. Immunol., 180, 309, 10.4049/jimmunol.180.1.309 · DOI · Paper page
- Bilich, 2021, T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals, Sci. Transl. Med., 13, eabf7517, 10.1126/scitranslmed.abf7517 · DOI · Paper page
- Habel, 2020, Suboptimal SARS-CoV-2-specific CD8(+) T cell response associated with the prominent HLA-A∗02:01 phenotype, Proc. Natl. Acad. Sci. USA, 117, 24384, 10.1073/pnas.2015486117 · DOI · Paper page
- Hu, 2022, Identification of cross-reactive CD8(+) T cell receptors with high functional avidity to a SARS-CoV-2 immunodominant epitope and its natural mutant variants, Genes Dis., 9, 216, 10.1016/j.gendis.2021.05.006 · DOI
- Joag, 2021, Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses, J. Immunol., 206, 931, 10.4049/jimmunol.2001400 · DOI
- Lee, 2021, Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity, J. Virol., 95, 10.1128/JVI.02002-20 · DOI
- Lineburg, 2021, CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses, Immunity, 54, 1055, 10.1016/j.immuni.2021.04.006 · DOI · Paper page
- Liu, 2010, The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes, J. Infect. Dis., 202, 1171, 10.1086/656315 · DOI · Paper page
- Nagler, 2021, Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics, Cell Rep., 35, 10.1016/j.celrep.2021.109305 · DOI · Paper page
- Nguyen, 2021, CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity, Immunity, 54, 1066, 10.1016/j.immuni.2021.04.009 · DOI
- Nielsen, 2021, SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity, EBioMedicine, 68, 10.1016/j.ebiom.2021.103410 · DOI
- Obermair, 2022, High-resolution profiling of MHC II peptide presentation capacity reveals SARS-CoV-2 CD4 T cell targets and mechanisms of immune escape, Sci. Adv., 8, 10.1126/sciadv.abl5394 · DOI
- Rha, 2021, PD-1-Expressing SARS-CoV-2-Specific CD8(+) T Cells Are Not Exhausted, but Functional in Patients with COVID-19, Immunity, 54, 44, 10.1016/j.immuni.2020.12.002 · DOI · Paper page
- Schreibing, 2022, Dissecting CD8+ T cell pathology of severe SARS-CoV-2 infection by single-cell immunoprofiling, Front. Immunol., 13, 10.3389/fimmu.2022.1066176 · DOI
- Shomuradova, 2020, SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors, Immunity, 53, 1245, 10.1016/j.immuni.2020.11.004 · DOI · Paper page
- Gallien, 2015, Large-Scale Targeted Proteomics Using Internal Standard Triggered-Parallel Reaction Monitoring (IS-PRM), Mol. Cell. Proteomics, 14, 1630, 10.1074/mcp.O114.043968 · DOI · Paper page
- Kent, 2002, The human genome browser at UCSC, Genome Res., 12, 996, 10.1101/gr.229102 · DOI · Paper page
- Hoffmann, 2020, SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052 · DOI · Paper page
- Fukushi, 2005, Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein, J. Gen. Virol., 86, 2269, 10.1099/vir.0.80955-0 · DOI · Paper page
- Lawson, 1995, Recombinant vesicular stomatitis viruses from DNA, Proc. Natl. Acad. Sci. USA, 92, 4477, 10.1073/pnas.92.10.4477 · DOI · Paper page
Cited by
Mapping the immunopeptidome of seven SARS-CoV-2 antigens across common HLA haplotypes
Braun, A., Rowntree, L. C., Huang, Z., Pandey, K., Thuesen, N., Li, C., Petersen, J., Littler, D. R., Raji, S., Nguyen, T. H. O., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51959-6 · Cited by 12
Metadata
- Authors
- Arieta, C. M., Xie, Y. J., Rothenberg, D. A., Diao, H., Harjanto, D., Meda, S., Marquart, K., Koenitzer, B., Sciuto, T. E., Lobo, A., Zuiani, A., Krumm, S. A., Cadima Couto, C. I., Hein, S., Heinen, A. P., Ziegenhals, T., Liu-Lupo, Y., Vogel, A. B., Srouji, J. R., Fesser, S., Thanki, K., Walzer, K., Addona, T. A., Türeci, Ö., Şahin, U., Gaynor, R. B., & Poran, A.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2023-05
- Volume
- 186
- Issue
- 11
- Pages
- 2392-2409.e21
- ISSN
- 0092-8674
- Cited by
- 91
- References
- 50
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.